Henry D - Search Results

1

Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies.

McGettigan P, Henry D. McGettigan P, et al. Among authors: henry d. PLoS Med. 2011 Sep;8(9):e1001098. doi: 10.1371/journal.pmed.1001098. Epub 2011 Sep 27. PLoS Med. 2011. PMID: 21980265 Free PMC article. Review.

2

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

McGettigan P, Henry D. McGettigan P, et al. Among authors: henry d. JAMA. 2006 Oct 4;296(13):1633-44. doi: 10.1001/jama.296.13.jrv60011. Epub 2006 Sep 12. JAMA. 2006. PMID: 16968831 Review.

3

The risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors does not vary with polymorphisms in two regions of the cyclo-oxygenase-2 gene.

McGettigan P, Lincz LF, Attia J, McElduff P, Bissett L, Peel R, Stokes B, Hancock S, Henderson K, Seldon M, Henry D. McGettigan P, et al. Among authors: henry d. Br J Clin Pharmacol. 2011 Oct;72(4):707-14. doi: 10.1111/j.1365-2125.2011.03957.x. Br J Clin Pharmacol. 2011. PMID: 21371074 Free PMC article.

4

Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries.

McGettigan P, Henry D. McGettigan P, et al. Among authors: henry d. PLoS Med. 2013;10(2):e1001388. doi: 10.1371/journal.pmed.1001388. Epub 2013 Feb 12. PLoS Med. 2013. PMID: 23424288 Free PMC article.

5

Epidemiology overview of gastrointestinal and renal toxicity of NSAIDs.

Henry D, McGettigan P. Henry D, et al. Int J Clin Pract Suppl. 2003 Apr;(135):43-9. Int J Clin Pract Suppl. 2003. PMID: 12723747 Review.

6

Cyclooxygenase-2 inhibitors and coronary occlusion--exploring dose-response relationships.

McGettigan P, Han P, Henry D. McGettigan P, et al. Among authors: henry d. Br J Clin Pharmacol. 2006 Sep;62(3):358-65. doi: 10.1111/j.1365-2125.2006.02660.x. Br J Clin Pharmacol. 2006. PMID: 16934052 Free PMC article.

7

Selective COX-2 inhibitors, NSAIDs and congestive heart failure: differences between new and recurrent cases.

McGettigan P, Han P, Jones L, Whitaker D, Henry D. McGettigan P, et al. Among authors: henry d. Br J Clin Pharmacol. 2008 Jun;65(6):927-34. doi: 10.1111/j.1365-2125.2008.03121.x. Epub 2008 Apr 1. Br J Clin Pharmacol. 2008. PMID: 18384446 Free PMC article.

8

Selective COX-2 inhibitors: a promise unfulfilled?

Henry D, McGettigan P. Henry D, et al. Gastroenterology. 2007 Feb;132(2):790-4. doi: 10.1053/j.gastro.2007.01.017. Gastroenterology. 2007. PMID: 17261306 No abstract available.

9

Describing treatment effects to patients.

Moxey A, O'Connell D, McGettigan P, Henry D. Moxey A, et al. Among authors: henry d. J Gen Intern Med. 2003 Nov;18(11):948-59. doi: 10.1046/j.1525-1497.2003.20928.x. J Gen Intern Med. 2003. PMID: 14687282 Free PMC article. Review.

10

Medical research and the news media.

McGettigan P, Henry D. McGettigan P, et al. Among authors: henry d. N Engl J Med. 2005 Feb 24;352(8):838-9; author reply 838-9. N Engl J Med. 2005. PMID: 15736294 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,389 results

Search Page